Metraipolis › archive › dc_6164e4251968

Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a… — Europe PMC PMID:42073639

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42073639
DOI
10.3390/cancers18081315
License (as archived)
solo-consultazione
Archived
2026-10-09T23:20:20.212Z
SHA-256 of the archived text
23178d917768b879c2a603a5841a758991ded3179297cce9767dfee0eaa9f786
Stable URL of this page
https://metraipolis.com/documento/dc_6164e4251968

How to cite

Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a… — Europe PMC PMID:42073639 — Europe PMC (en), https://europepmc.org/article/MED/42073639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6164e4251968 (Metraipolis archive dc_6164e4251968, sha256 23178d917768b879c2a603a5841a758991ded3179297cce9767dfee0eaa9f786)
BibTeX
@misc{dc6164e4251968,
  title = {Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a… — Europe PMC PMID:42073639},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42073639},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6164e4251968; sha256 23178d917768b879c2a603a5841a758991ded3179297cce9767dfee0eaa9f786},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42073639. Agents can read the archived copy with the MCP tool read_document.